3rd Quarter - Report

FORBES-TATE for ADAPT PHARMA INC.

Firm
Client
Income
$120,000
Expenses
—

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues related to CARA implementation; Issues related to opioid abuse; Issues related to FDA; Issues related to FY 2018 Appropriations implementation; Issues related FY 2019 Appropriations; Issues related to CDC; Issues related to HHS; Issues related to DOJ; Issues related to funding for community-based nalaxone; Issues related to ONDCP funding.

LobbyistCovered position, as disclosed
JERRY DRISCOLL —
ELIZABETH GREER —
RICK MURPHY —
EDWARD C. RENO —
JEFFREY SADOSKY —
WESLEY RYAN WELCH —
DERRICK M WHITE —
ZACHARY WILLIAMS —

Contacted: Health & Human Services, Dept of (HHS); Office of Management & Budget (OMB); SENATE; Justice, Dept of (DOJ); Substance Abuse & Mental Health Services Administration (SAMHSA); HOUSE OF REPRESENTATIVES; Office of Natl Drug Control Policy (NDCP); Centers For Disease Control & Prevention (CDC)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.